Software-Guided heart procedures: a new standard for coronary care?
NCT ID NCT07766434
First seen Aug 14, 2026 · Last updated Aug 14, 2026
Summary
This study is a large, real-world registry that will include over 10,000 people with coronary artery disease from more than 50 hospitals across China. The goal is to see how often a software tool called QFR, which analyzes angiogram images to guide treatment decisions, is used in practice. Researchers will also track heart-related events like heart attacks and repeat procedures to evaluate the quality of care.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Quantitative Flow Ratio (QFR) - a software-based tool that analyzes coronary angiograms to guide revascularization decisions
- What this could lead to
- If successful, this could establish a quality standard for using QFR to guide coronary procedures, potentially improving outcomes for heart disease patients.
- What could go wrong
- This is an observational registry, not a controlled trial, so it cannot prove cause and effect. The results may vary across centers and may not generalize beyond China.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CORONARY ARTERY DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
National Clinical Research Center of Cardiovascular Diseases, National Center for Cardiovascular Diseases, Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
Beijing, Beijing Municipality, 100037, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Heart patients may stay active longer with coach calls and group support
- Sitting less could be a lifeline for frail hearts – a new trial tests a simple program
- Can balloon timing make or break heart artery success?
- Can we predict which heart aneurysms will grow?
- Can a higher dose of adenosine sharpen heart scans?
- One scan, many answers: can a new CT predict heart risks after stenting?